BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 22160329)

  • 1. Development and structure of a novel barrier membrane composed of drug-loaded poly(lactic-co-glycolic acid) particles for guided bone regeneration.
    Son JS; Kim SG; Jin SC; Piao ZG; Lee SY; Oh JS; Kim CS; Kim BH; Jeong MA
    Biotechnol Lett; 2012 Apr; 34(4):779-87. PubMed ID: 22160329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Porous hydroxyapatite scaffold with three-dimensional localized drug delivery system using biodegradable microspheres.
    Son JS; Appleford M; Ong JL; Wenke JC; Kim JM; Choi SH; Oh DS
    J Control Release; 2011 Jul; 153(2):133-40. PubMed ID: 21420453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained release of dexamethasone from hydrophilic matrices using PLGA nanoparticles for neural drug delivery.
    Kim DH; Martin DC
    Biomaterials; 2006 May; 27(15):3031-7. PubMed ID: 16443270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(lactic-co-glycolic) acid loaded nano-insulin has greater potentials of combating arsenic induced hyperglycemia in mice: some novel findings.
    Samadder A; Das J; Das S; De A; Saha SK; Bhattacharyya SS; Khuda-Bukhsh AR
    Toxicol Appl Pharmacol; 2013 Feb; 267(1):57-73. PubMed ID: 23276653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and optimization of NSAID loaded nanoparticles.
    Sashmal S; Mukherjee S; Ray S; Thakur RS; Ghosh LK; Gupta BK
    Pak J Pharm Sci; 2007 Apr; 20(2):157-62. PubMed ID: 17416573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexamethasone acetate encapsulation into Trojan particles.
    Gómez-Gaete C; Fattal E; Silva L; Besnard M; Tsapis N
    J Control Release; 2008 May; 128(1):41-9. PubMed ID: 18374442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HP55-coated capsule containing PLGA/RS nanoparticles for oral delivery of insulin.
    Wu ZM; Zhou L; Guo XD; Jiang W; Ling L; Qian Y; Luo KQ; Zhang LJ
    Int J Pharm; 2012 Apr; 425(1-2):1-8. PubMed ID: 22248666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An in vitro study of plasticized poly(lactic-co-glycolic acid) films as possible guided tissue regeneration membranes: material properties and drug release kinetics.
    Owen GR; Jackson JK; Chehroudi B; Brunette DM; Burt HM
    J Biomed Mater Res A; 2010 Dec; 95(3):857-69. PubMed ID: 20824651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticle infiltration to prepare solvent-free controlled drug delivery systems.
    Rodríguez-Cruz IM; Domínguez-Delgado CL; Escobar-Chávez JJ; Leyva-Gómez G; Ganem-Quintanar A; Quintanar-Guerrero D
    Int J Pharm; 2009 Apr; 371(1-2):177-81. PubMed ID: 19150491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles.
    Niu X; Zou W; Liu C; Zhang N; Fu C
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1375-83. PubMed ID: 19832638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bupivacaine-loaded biodegradable poly(lactic-co-glycolic) acid microspheres I. Optimization of the drug incorporation into the polymer matrix and modelling of drug release.
    Zhang H; Lu Y; Zhang G; Gao S; Sun D; Zhong Y
    Int J Pharm; 2008 Mar; 351(1-2):244-9. PubMed ID: 18024022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives.
    Mundargi RC; Babu VR; Rangaswamy V; Patel P; Aminabhavi TM
    J Control Release; 2008 Feb; 125(3):193-209. PubMed ID: 18083265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
    Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
    Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrophilized polycaprolactone nanofiber mesh-embedded poly(glycolic-co-lactic acid) membrane for effective guided bone regeneration.
    Cho WJ; Kim JH; Oh SH; Nam HH; Kim JM; Lee JH
    J Biomed Mater Res A; 2009 Nov; 91(2):400-7. PubMed ID: 18980200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guided bone regeneration by poly(lactic-co-glycolic acid) grafted hyaluronic acid bi-layer films for periodontal barrier applications.
    Park JK; Yeom J; Oh EJ; Reddy M; Kim JY; Cho DW; Lim HP; Kim NS; Park SW; Shin HI; Yang DJ; Park KB; Hahn SK
    Acta Biomater; 2009 Nov; 5(9):3394-403. PubMed ID: 19477304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro release characteristics and cellular uptake of poly(D,L-lactic-co-glycolic acid) nanoparticles for topical delivery of antisense oligodeoxynucleotides.
    Chen YS; Alany RG; Young SA; Green CR; Rupenthal ID
    Drug Deliv; 2011; 18(7):493-501. PubMed ID: 21696294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fabrication of covered porous PLGA microspheres using hydrogen peroxide for controlled drug delivery and regenerative medicine.
    Bae SE; Son JS; Park K; Han DK
    J Control Release; 2009 Jan; 133(1):37-43. PubMed ID: 18838089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of an injectable composite as a carrier for growth factor-enhanced periodontal regeneration.
    Herberg S; Siedler M; Pippig S; Schuetz A; Dony C; Kim CK; Wikesjö UM
    J Clin Periodontol; 2008 Nov; 35(11):976-84. PubMed ID: 18976394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and characterization of PLGA particles for subcutaneous controlled drug release by membrane emulsification.
    Gasparini G; Kosvintsev SR; Stillwell MT; Holdich RG
    Colloids Surf B Biointerfaces; 2008 Feb; 61(2):199-207. PubMed ID: 17919891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis.
    Ohashi K; Kabasawa T; Ozeki T; Okada H
    J Control Release; 2009 Apr; 135(1):19-24. PubMed ID: 19121349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.